These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 67900)

  • 1. Studies on the regulation of lymphocyte reactivity by normal and activated macrophages.
    Wing EJ; Remington JS
    Cell Immunol; 1977 Apr; 30(1):108-21. PubMed ID: 67900
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of Corynebacterium parvum treatment and Toxoplasma gondii infection on macrophage-mediated cytostasis of tumour target cells.
    Krahenbuhl JL; Lambert LH; Remington JS
    Immunology; 1976 Dec; 31(6):837-46. PubMed ID: 992714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of macrophage activation by Corynebacterium parvum. I. In vitro experiments.
    Christie GH; Bomford R
    Cell Immunol; 1975 May; 17(1):141-9. PubMed ID: 1092470
    [No Abstract]   [Full Text] [Related]  

  • 4. [Equal sensitivity of normal or tumoral fibroblasts to cytotoxic and cytostatic effects of normal or "Corynebacterium parvum" activated peritoneal exudate cells (author's transl)].
    Fray A; Lorinet AM; Thobie N; Halpern B
    Ann Immunol (Paris); 1979; 130C(3):445-59. PubMed ID: 475346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of activated macrophages in specific and nonspecific cytostasis of tumor cells.
    Krahenbuhl JL; Remington JS
    J Immunol; 1974 Aug; 113(2):507-16. PubMed ID: 4210882
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of activated macrophages on tumor target cells: escape from cytostasis.
    Krahenbuhl JL; Lambert LH; Remington JS
    Cell Immunol; 1976 Aug; 25(2):279-93. PubMed ID: 821620
    [No Abstract]   [Full Text] [Related]  

  • 7. [Demonstration of antigen-specific suppressor cells in Toxoplasma infection of man].
    Müller WA
    Angew Parasitol; 1984 Aug; 25(3):120-6. PubMed ID: 6208819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 3H-thymidine incorporation of lymphocytes by a soluble factor from macrophages.
    Opitz HG; Niethammer D; Lemke H; Flad HD; Huget R
    Cell Immunol; 1975 Apr; 16(2):379-88. PubMed ID: 1116176
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of macrophages in the tumor-induced suppression of mitogen responses in rats.
    Kruisbeek AM; van Hees M
    J Natl Cancer Inst; 1977 Jun; 58(6):1653-60. PubMed ID: 301195
    [No Abstract]   [Full Text] [Related]  

  • 10. Production by stimulated macrophages of factors depressing lymphocyte transformation.
    Nelson DS
    Nature; 1973 Nov; 246(5431):306-7. PubMed ID: 4148524
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antitumor efficacy of activated macrophages against murine glioma cells].
    Miyao Y; Shimizu K; Okamoto Y; Matsui Y; Ushio Y; Hayakawa T; Tsuda N; Mogami H
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2082-8. PubMed ID: 3717955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of colony-stimulating factor in mitogen-stimulated lymphocyte cultures.
    Parker JW; Metcalf D
    J Immunol; 1974 Feb; 112(2):502-10. PubMed ID: 4591973
    [No Abstract]   [Full Text] [Related]  

  • 13. Specific lymphocyte-activating determinants expressed on mouse macrophages.
    Schirrmacher V; Peña-Martinez J; Festenstein H
    Nature; 1975 May; 255(5504):155-6. PubMed ID: 48201
    [No Abstract]   [Full Text] [Related]  

  • 14. A role for the macrophage in in vivo and in vitro resistance to murine bladder tumor cell growth.
    Droller MJ; Remington JS
    Cancer Res; 1975 Jan; 35(1):49-53. PubMed ID: 1109796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological effects of the adjuvant Corynebacterium parvum. II. Evidence for macrophage-T-cell interaction.
    Scott MT
    Cell Immunol; 1972 Nov; 5(3):469-79. PubMed ID: 4405135
    [No Abstract]   [Full Text] [Related]  

  • 16. Some observations on the in vitro reactivity of lymphoid subpopulations.
    Diamond B; Knight SC; Lance EM
    Cell Immunol; 1974 Mar; 11(1-3):239-46. PubMed ID: 4281723
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocyte classes in New Zealand mice. I. Ontogeny and mitogen responsiveness of thymocytes and thymus-derived lymphocytes.
    Stobo JD; Talal N; Paul WE
    J Immunol; 1972 Oct; 109(4):692-700. PubMed ID: 4116356
    [No Abstract]   [Full Text] [Related]  

  • 18. Susceptibility of malignant and normal target cells to the cytotoxic action of bone-marrow macrophages activated in vitro with the macrophage cytotoxicity factor (MCF).
    Lohmann-Matthes ML; Kolb B; Meerpohl HG
    Cell Immunol; 1978 Dec; 41(2):231-9. PubMed ID: 729007
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of a thymus dependent hymoral response in mice by concanavalin A in vivo.
    Egan HS; Ekstedt RD
    Cell Immunol; 1975 Aug; 18(2):365-74. PubMed ID: 1095216
    [No Abstract]   [Full Text] [Related]  

  • 20. Properties of fractionated spleen cells from NZB/W mice.
    Garner GM; Gershwin ME; Steinberg AD
    Cell Immunol; 1975 Jan; 15(1):129-42. PubMed ID: 45836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.